Показано 0 из 0
Дата |
---|
02.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
19.06.2024 |
18.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
|
0.4525
|
0.505
|
0.49
|
|
|
601 887.58
|
|
|
|
|
0.565
|
0.62
|
0.60
|
|
|
158 336.40
|
|
|
|
|
0.53
|
0.57
|
0.57
|
|
|
127 089.48
|
|
|
|
|
0.515
|
0.555
|
0.535
|
|
|
82 131.60
|
|
|
|
|
0.53
|
0.56
|
0.53
|
|
|
29 826.28
|
|
|
|
|
0.545
|
0.58
|
0.545
|
|
|
72 306.24
|
|
|
|
|
0.575
|
0.58
|
0.575
|
|
|
13 441.20
|
|
|
|
|
0.58
|
0.595
|
0.595
|
|
|
30 534.21
|
|
|
|
|
0.57
|
0.595
|
0.59
|
|
|
85 934.09
|
|
|
|
|
0.555
|
0.59
|
0.59
|
|
|
130 650.78
|
|
Recce Pharmaceuticals Ltd operates as a pre-clinical-stage pharmaceutical company. The Company produces antibiotics for human use to address the crisis of superbugs. Recce Pharmaceuticals develops synthetic antibiotics to address the threat to human health from antibiotic resistant bacteria. Recce Pharmaceuticals serves customers in Australia.